Global Next Generation Cancer Diagnostics Market Insights and Forecast to 2028

Q: How big is the next generation cancer diagnostics market?

Market Analysis and Insights Global Next Generation Cancer Diagnostics MarketThe global Next Generation Cancer Diagnostics market size is projected to reach US 20950 million by 2028 from US 6198.2 million in 2021 at a CAGR of 18.5 during 20222028.Fully considering the economic change by this health crisis Next Generation Sequencing accounting for of the Next Generation Cancer Diagnostics global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

Q: Who are the key players in the next generation cancer diagnostics market?

Some of the key players are Cepheid Inc, Koninklijke Philips N V, F Hoffmann La Roche Ltd, Qiagen NV, Novartis, Abbott, Thermo Fisher Scientific, OPKO Health, Myriad Genetics, Agilent Technologies, GE Healthcare, PerkinElmer Inc, Genomic Health, Illumina Inc, Hologic Inc, Almac Group, Janssen Global Services, Sysmex Corporation, China, Koninklijke, Cepheid, India, Others.

Code: QYRE-Auto-24F2154

Report

February 2022

113 Pages

QYResearch

Region: Global, North America, Europe, Japan, Central & South America,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Cepheid Inc

Koninklijke Philips N V

F Hoffmann La Roche Ltd

Qiagen NV

Novartis

Abbott

Thermo Fisher Scientific

OPKO Health

Myriad Genetics

Agilent Technologies

GE Healthcare

PerkinElmer Inc

Genomic Health

Illumina Inc

Hologic Inc

Almac Group

Janssen Global Services

Sysmex Corporation

China

Koninklijke

Cepheid

India

Market Analysis and Insights: Global Next Generation Cancer Diagnostics Market

The global Next Generation Cancer Diagnostics market size is projected to reach US$ 20950 million by 2028, from US$ 6198.2 million in 2021, at a CAGR of 18.5% during 2022-2028.

Fully considering the economic change by this health crisis, Next Generation Sequencing accounting for % of the Next Generation Cancer Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Next Generation Cancer Diagnostics market size is valued at US$ million in 2021, while the North America and Europe Next Generation Cancer Diagnostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Next Generation Cancer Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Cancer Diagnostics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Cancer Diagnostics market.

Global Next Generation Cancer Diagnostics Scope and Market Size

Next Generation Cancer Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Next Generation Sequencing

qPCR & Multiplexing

DNA Microarrays

Others

Segment by Application

Hospitals

Clinics

Others

BY COMPANY

Cepheid

Koninklijke Philips N.V

F. Hoffmann-La Roche Ltd

Qiagen

Novartis AG

Abbott

Thermo Fisher Scientific

Opko Health

Myriad Genetics

Agilent Technologies

GE Healthcare

PerkinElmer

Genomic Health

Illumina

Hologic

Almac Group

Janssen Global Services

Sysmex Corporation

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Cepheid Inc

Koninklijke Philips N V

F Hoffmann La Roche Ltd

Qiagen NV

Novartis

Abbott

Thermo Fisher Scientific

OPKO Health

Myriad Genetics

Agilent Technologies

GE Healthcare

PerkinElmer Inc

Genomic Health

Illumina Inc

Hologic Inc

Almac Group

Janssen Global Services

Sysmex Corporation

China

Koninklijke

Cepheid

India

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Next Generation Sequencing

1.2.3 qPCR & Multiplexing

1.2.4 DNA Microarrays

1.2.5 Others

1.3 Market by Application

1.3.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Next Generation Cancer Diagnostics Market Perspective (2017-2028)

2.2 Next Generation Cancer Diagnostics Growth Trends by Region

2.2.1 Next Generation Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Next Generation Cancer Diagnostics Historic Market Size by Region (2017-2022)

2.2.3 Next Generation Cancer Diagnostics Forecasted Market Size by Region (2023-2028)

2.3 Next Generation Cancer Diagnostics Market Dynamics

2.3.1 Next Generation Cancer Diagnostics Industry Trends

2.3.2 Next Generation Cancer Diagnostics Market Drivers

2.3.3 Next Generation Cancer Diagnostics Market Challenges

2.3.4 Next Generation Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next Generation Cancer Diagnostics Players by Revenue

3.1.1 Global Top Next Generation Cancer Diagnostics Players by Revenue (2017-2022)

3.1.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Players (2017-2022)

3.2 Global Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Next Generation Cancer Diagnostics Revenue

3.4 Global Next Generation Cancer Diagnostics Market Concentration Ratio

3.4.1 Global Next Generation Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostics Revenue in 2021

3.5 Next Generation Cancer Diagnostics Key Players Head office and Area Served

3.6 Key Players Next Generation Cancer Diagnostics Product Solution and Service

3.7 Date of Enter into Next Generation Cancer Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Cancer Diagnostics Breakdown Data by Type

4.1 Global Next Generation Cancer Diagnostics Historic Market Size by Type (2017-2022)

4.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2023-2028)

5 Next Generation Cancer Diagnostics Breakdown Data by Application

5.1 Global Next Generation Cancer Diagnostics Historic Market Size by Application (2017-2022)

5.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Next Generation Cancer Diagnostics Market Size (2017-2028)

6.2 North America Next Generation Cancer Diagnostics Market Size by Type

6.2.1 North America Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

6.2.2 North America Next Generation Cancer Diagnostics Market Size by Type (2023-2028)

6.2.3 North America Next Generation Cancer Diagnostics Market Share by Type (2017-2028)

6.3 North America Next Generation Cancer Diagnostics Market Size by Application

6.3.1 North America Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

6.3.2 North America Next Generation Cancer Diagnostics Market Size by Application (2023-2028)

6.3.3 North America Next Generation Cancer Diagnostics Market Share by Application (2017-2028)

6.4 North America Next Generation Cancer Diagnostics Market Size by Country

6.4.1 North America Next Generation Cancer Diagnostics Market Size by Country (2017-2022)

6.4.2 North America Next Generation Cancer Diagnostics Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Next Generation Cancer Diagnostics Market Size (2017-2028)

7.2 Europe Next Generation Cancer Diagnostics Market Size by Type

7.2.1 Europe Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

7.2.2 Europe Next Generation Cancer Diagnostics Market Size by Type (2023-2028)

7.2.3 Europe Next Generation Cancer Diagnostics Market Share by Type (2017-2028)

7.3 Europe Next Generation Cancer Diagnostics Market Size by Application

7.3.1 Europe Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

7.3.2 Europe Next Generation Cancer Diagnostics Market Size by Application (2023-2028)

7.3.3 Europe Next Generation Cancer Diagnostics Market Share by Application (2017-2028)

7.4 Europe Next Generation Cancer Diagnostics Market Size by Country

7.4.1 Europe Next Generation Cancer Diagnostics Market Size by Country (2017-2022)

7.4.2 Europe Next Generation Cancer Diagnostics Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size (2017-2028)

8.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type

8.2.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Next Generation Cancer Diagnostics Market Share by Type (2017-2028)

8.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application

8.3.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Next Generation Cancer Diagnostics Market Share by Application (2017-2028)

8.4 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region

8.4.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Next Generation Cancer Diagnostics Market Size (2017-2028)

9.2 Latin America Next Generation Cancer Diagnostics Market Size by Type

9.2.1 Latin America Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

9.2.2 Latin America Next Generation Cancer Diagnostics Market Size by Type (2023-2028)

9.2.3 Latin America Next Generation Cancer Diagnostics Market Share by Type (2017-2028)

9.3 Latin America Next Generation Cancer Diagnostics Market Size by Application

9.3.1 Latin America Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

9.3.2 Latin America Next Generation Cancer Diagnostics Market Size by Application (2023-2028)

9.3.3 Latin America Next Generation Cancer Diagnostics Market Share by Application (2017-2028)

9.4 Latin America Next Generation Cancer Diagnostics Market Size by Country

9.4.1 Latin America Next Generation Cancer Diagnostics Market Size by Country (2017-2022)

9.4.2 Latin America Next Generation Cancer Diagnostics Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size (2017-2028)

10.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type

10.2.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Next Generation Cancer Diagnostics Market Share by Type (2017-2028)

10.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application

10.3.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Next Generation Cancer Diagnostics Market Share by Application (2017-2028)

10.4 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country

10.4.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Cepheid

11.1.1 Cepheid Company Details

11.1.2 Cepheid Business Overview

11.1.3 Cepheid Next Generation Cancer Diagnostics Introduction

11.1.4 Cepheid Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.1.5 Cepheid Recent Developments

11.2 Koninklijke Philips N.V

11.2.1 Koninklijke Philips N.V Company Details

11.2.2 Koninklijke Philips N.V Business Overview

11.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Introduction

11.2.4 Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.2.5 Koninklijke Philips N.V Recent Developments

11.3 F. Hoffmann-La Roche Ltd

11.3.1 F. Hoffmann-La Roche Ltd Company Details

11.3.2 F. Hoffmann-La Roche Ltd Business Overview

11.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Introduction

11.3.4 F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.3.5 F. Hoffmann-La Roche Ltd Recent Developments

11.4 Qiagen

11.4.1 Qiagen Company Details

11.4.2 Qiagen Business Overview

11.4.3 Qiagen Next Generation Cancer Diagnostics Introduction

11.4.4 Qiagen Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.4.5 Qiagen Recent Developments

11.5 Novartis AG

11.5.1 Novartis AG Company Details

11.5.2 Novartis AG Business Overview

11.5.3 Novartis AG Next Generation Cancer Diagnostics Introduction

11.5.4 Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.5.5 Novartis AG Recent Developments

11.6 Abbott

11.6.1 Abbott Company Details

11.6.2 Abbott Business Overview

11.6.3 Abbott Next Generation Cancer Diagnostics Introduction

11.6.4 Abbott Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.6.5 Abbott Recent Developments

11.7 Thermo Fisher Scientific

11.7.1 Thermo Fisher Scientific Company Details

11.7.2 Thermo Fisher Scientific Business Overview

11.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Introduction

11.7.4 Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.7.5 Thermo Fisher Scientific Recent Developments

11.8 Opko Health

11.8.1 Opko Health Company Details

11.8.2 Opko Health Business Overview

11.8.3 Opko Health Next Generation Cancer Diagnostics Introduction

11.8.4 Opko Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.8.5 Opko Health Recent Developments

11.9 Myriad Genetics

11.9.1 Myriad Genetics Company Details

11.9.2 Myriad Genetics Business Overview

11.9.3 Myriad Genetics Next Generation Cancer Diagnostics Introduction

11.9.4 Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.9.5 Myriad Genetics Recent Developments

11.10 Agilent Technologies

11.10.1 Agilent Technologies Company Details

11.10.2 Agilent Technologies Business Overview

11.10.3 Agilent Technologies Next Generation Cancer Diagnostics Introduction

11.10.4 Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.10.5 Agilent Technologies Recent Developments

11.11 GE Healthcare

11.11.1 GE Healthcare Company Details

11.11.2 GE Healthcare Business Overview

11.11.3 GE Healthcare Next Generation Cancer Diagnostics Introduction

11.11.4 GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.11.5 GE Healthcare Recent Developments

11.12 PerkinElmer

11.12.1 PerkinElmer Company Details

11.12.2 PerkinElmer Business Overview

11.12.3 PerkinElmer Next Generation Cancer Diagnostics Introduction

11.12.4 PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.12.5 PerkinElmer Recent Developments

11.13 Genomic Health

11.13.1 Genomic Health Company Details

11.13.2 Genomic Health Business Overview

11.13.3 Genomic Health Next Generation Cancer Diagnostics Introduction

11.13.4 Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.13.5 Genomic Health Recent Developments

11.14 Illumina

11.14.1 Illumina Company Details

11.14.2 Illumina Business Overview

11.14.3 Illumina Next Generation Cancer Diagnostics Introduction

11.14.4 Illumina Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.14.5 Illumina Recent Developments

11.15 Hologic

11.15.1 Hologic Company Details

11.15.2 Hologic Business Overview

11.15.3 Hologic Next Generation Cancer Diagnostics Introduction

11.15.4 Hologic Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.15.5 Hologic Recent Developments

11.16 Almac Group

11.16.1 Almac Group Company Details

11.16.2 Almac Group Business Overview

11.16.3 Almac Group Next Generation Cancer Diagnostics Introduction

11.16.4 Almac Group Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.16.5 Almac Group Recent Developments

11.17 Janssen Global Services

11.17.1 Janssen Global Services Company Details

11.17.2 Janssen Global Services Business Overview

11.17.3 Janssen Global Services Next Generation Cancer Diagnostics Introduction

11.17.4 Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.17.5 Janssen Global Services Recent Developments

11.18 Sysmex Corporation

11.18.1 Sysmex Corporation Company Details

11.18.2 Sysmex Corporation Business Overview

11.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Introduction

11.18.4 Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2017-2022)

11.18.5 Sysmex Corporation Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Cepheid Inc

Koninklijke Philips N V

F Hoffmann La Roche Ltd

Qiagen NV

Novartis

Abbott

Thermo Fisher Scientific

OPKO Health

Myriad Genetics

Agilent Technologies

GE Healthcare

PerkinElmer Inc

Genomic Health

Illumina Inc

Hologic Inc

Almac Group

Janssen Global Services

Sysmex Corporation

China

Koninklijke

Cepheid

India

List of Tables

Table 1. Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Next Generation Sequencing

Table 3. Key Players of qPCR & Multiplexing

Table 4. Key Players of DNA Microarrays

Table 5. Key Players of Others

Table 6. Global Next Generation Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 7. Global Next Generation Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 8. Global Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)

Table 9. Global Next Generation Cancer Diagnostics Market Share by Region (2017-2022)

Table 10. Global Next Generation Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 11. Global Next Generation Cancer Diagnostics Market Share by Region (2023-2028)

Table 12. Next Generation Cancer Diagnostics Market Trends

Table 13. Next Generation Cancer Diagnostics Market Drivers

Table 14. Next Generation Cancer Diagnostics Market Challenges

Table 15. Next Generation Cancer Diagnostics Market Restraints

Table 16. Global Next Generation Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)

Table 17. Global Next Generation Cancer Diagnostics Revenue Share by Players (2017-2022)

Table 18. Global Top Next Generation Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2021)

Table 19. Ranking of Global Top Next Generation Cancer Diagnostics Companies by Revenue (US$ Million) in 2021

Table 20. Global 5 Largest Players Market Share by Next Generation Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Next Generation Cancer Diagnostics Product Solution and Service

Table 23. Date of Enter into Next Generation Cancer Diagnostics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 26. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2017-2022)

Table 27. Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 28. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2023-2028)

Table 29. Global Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 30. Global Next Generation Cancer Diagnostics Revenue Share by Application (2017-2022)

Table 31. Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 32. Global Next Generation Cancer Diagnostics Revenue Share by Application (2023-2028)

Table 33. North America Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 34. North America Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 35. North America Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 36. North America Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 37. North America Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)

Table 38. North America Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)

Table 39. Europe Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 40. Europe Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 41. Europe Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 42. Europe Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 43. Europe Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)

Table 44. Europe Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)

Table 45. Asia Pacific Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 46. Asia Pacific Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 47. Asia Pacific Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 48. Asia Pacific Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 49. Asia Pacific Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)

Table 50. Asia Pacific Next Generation Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)

Table 51. Latin America Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 52. Latin America Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 53. Latin America Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 54. Latin America Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 55. Latin America Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)

Table 56. Latin America Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)

Table 63. Cepheid Company Details

Table 64. Cepheid Business Overview

Table 65. Cepheid Next Generation Cancer Diagnostics Product

Table 66. Cepheid Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 67. Cepheid Recent Developments

Table 68. Koninklijke Philips N.V Company Details

Table 69. Koninklijke Philips N.V Business Overview

Table 70. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product

Table 71. Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 72. Koninklijke Philips N.V Recent Developments

Table 73. F. Hoffmann-La Roche Ltd Company Details

Table 74. F. Hoffmann-La Roche Ltd Business Overview

Table 75. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product

Table 76. F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 77. F. Hoffmann-La Roche Ltd Recent Developments

Table 78. Qiagen Company Details

Table 79. Qiagen Business Overview

Table 80. Qiagen Next Generation Cancer Diagnostics Product

Table 81. Qiagen Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 82. Qiagen Recent Developments

Table 83. Novartis AG Company Details

Table 84. Novartis AG Business Overview

Table 85. Novartis AG Next Generation Cancer Diagnostics Product

Table 86. Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 87. Novartis AG Recent Developments

Table 88. Abbott Company Details

Table 89. Abbott Business Overview

Table 90. Abbott Next Generation Cancer Diagnostics Product

Table 91. Abbott Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 92. Abbott Recent Developments

Table 93. Thermo Fisher Scientific Company Details

Table 94. Thermo Fisher Scientific Business Overview

Table 95. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product

Table 96. Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 97. Thermo Fisher Scientific Recent Developments

Table 98. Opko Health Company Details

Table 99. Opko Health Business Overview

Table 100. Opko Health Next Generation Cancer Diagnostics Product

Table 101. Opko Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 102. Opko Health Recent Developments

Table 103. Myriad Genetics Company Details

Table 104. Myriad Genetics Business Overview

Table 105. Myriad Genetics Next Generation Cancer Diagnostics Product

Table 106. Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 107. Myriad Genetics Recent Developments

Table 108. Agilent Technologies Company Details

Table 109. Agilent Technologies Business Overview

Table 110. Agilent Technologies Next Generation Cancer Diagnostics Product

Table 111. Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 112. Agilent Technologies Recent Developments

Table 113. GE Healthcare Company Details

Table 114. GE Healthcare Business Overview

Table 115. GE Healthcare Next Generation Cancer Diagnostics Product

Table 116. GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 117. GE Healthcare Recent Developments

Table 118. PerkinElmer Company Details

Table 119. PerkinElmer Business Overview

Table 120. PerkinElmer Next Generation Cancer Diagnostics Product

Table 121. PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 122. PerkinElmer Recent Developments

Table 123. Genomic Health Company Details

Table 124. Genomic Health Business Overview

Table 125. Genomic Health Next Generation Cancer Diagnostics Product

Table 126. Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 127. Genomic Health Recent Developments

Table 128. Illumina Company Details

Table 129. Illumina Business Overview

Table 130. Illumina Next Generation Cancer Diagnostics Product

Table 131. Illumina Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 132. Illumina Recent Developments

Table 133. Hologic Company Details

Table 134. Hologic Business Overview

Table 135. Hologic Next Generation Cancer Diagnostics Product

Table 136. Hologic Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 137. Hologic Recent Developments

Table 138. Almac Group Company Details

Table 139. Almac Group Business Overview

Table 140. Almac Group Next Generation Cancer Diagnostics Product

Table 141. Almac Group Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 142. Almac Group Recent Developments

Table 143. Janssen Global Services Company Details

Table 144. Janssen Global Services Business Overview

Table 145. Janssen Global Services Next Generation Cancer Diagnostics Product

Table 146. Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 147. Janssen Global Services Recent Developments

Table 148. Sysmex Corporation Company Details

Table 149. Sysmex Corporation Business Overview

Table 150. Sysmex Corporation Next Generation Cancer Diagnostics Product

Table 151. Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)

Table 152. Sysmex Corporation Recent Developments

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Next Generation Cancer Diagnostics Market Share by Type: 2021 VS 2028

Figure 2. Next Generation Sequencing Features

Figure 3. qPCR & Multiplexing Features

Figure 4. DNA Microarrays Features

Figure 5. Others Features

Figure 6. Global Next Generation Cancer Diagnostics Market Share by Application: 2021 VS 2028

Figure 7. Hospitals Case Studies

Figure 8. Clinics Case Studies

Figure 9. Others Case Studies

Figure 10. Next Generation Cancer Diagnostics Report Years Considered

Figure 11. Global Next Generation Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 12. Global Next Generation Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Next Generation Cancer Diagnostics Market Share by Region: 2021 VS 2028

Figure 14. Global Next Generation Cancer Diagnostics Market Share by Players in 2021

Figure 15. Global Top Next Generation Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2021)

Figure 16. The Top 10 and 5 Players Market Share by Next Generation Cancer Diagnostics Revenue in 2021

Figure 17. North America Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 18. North America Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)

Figure 19. North America Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)

Figure 20. North America Next Generation Cancer Diagnostics Market Size Share by Country (2017-2028)

Figure 21. United States Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Canada Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Europe Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 24. Europe Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)

Figure 25. Europe Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)

Figure 26. Europe Next Generation Cancer Diagnostics Market Size Share by Country (2017-2028)

Figure 27. Germany Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. France Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. U.K. Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Italy Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Russia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Nordic Countries Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 34. Asia Pacific Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)

Figure 35. Asia Pacific Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)

Figure 36. Asia Pacific Next Generation Cancer Diagnostics Market Size Share by Region (2017-2028)

Figure 37. China Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Japan Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. South Korea Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Southeast Asia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. India Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Australia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 43. Latin America Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 44. Latin America Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)

Figure 45. Latin America Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)

Figure 46. Latin America Next Generation Cancer Diagnostics Market Size Share by Country (2017-2028)

Figure 47. Mexico Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Brazil Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Middle East & Africa Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 50. Middle East and Africa Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)

Figure 51. Middle East and Africa Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)

Figure 52. Middle East and Africa Next Generation Cancer Diagnostics Market Size Share by Country (2017-2028)

Figure 53. Turkey Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Saudi Arabia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. UAE Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. Cepheid Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 57. Koninklijke Philips N.V Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 59. Qiagen Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 60. Novartis AG Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 61. Abbott Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 63. Opko Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 64. Myriad Genetics Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 65. Agilent Technologies Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 66. GE Healthcare Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 67. PerkinElmer Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 68. Genomic Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 69. Illumina Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 70. Hologic Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 71. Almac Group Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 72. Janssen Global Services Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 73. Sysmex Corporation Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global Next Generation Cancer Diagnostics Market Insights and Forecast to 2028

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Next Generation Cancer Diagnostics Market Insights and Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-24F2154

Global Next Generation Cancer Diagnostics Market Insights and Forecast to 2028

Code: QYRE-Auto-24F2154

Report

February 2022

113 Pages

QYResearch

Region: Global, North America, Europe, Japan, Central & South America,

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$4900

Multi User

Electronic (PDF)

$7350

Enterprise User

Electronic (PDF)

$9800

HAVE A QUERY?

OUR CUSTOMER

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-24U5687

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-23K5690

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-18N5929

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-12C6010

Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions